Gracell Biotechnologies Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| – | +177.6% | +134.1% | +113.5% | -19.6% | |
| – | +166.0% | +139.6% | +131.2% | -20.7% | |
| – | +2,524.5% | +141.7% | +142.5% | -20.5% | |
| – | +177.7% | +144.4% | +137.1% | -20.4% | |
| – | +122.1% | +124.8% | +31.4% | -35.3% | |
| – | +21.9% | -429.9% | – | -402.7% | |
| – | +196.7% | +146.4% | +28.9% | -5.7% | |
| – | +7.3% | -7.4% | +60.2% | +20.5% | |
| – | +144.2% | +413.9% | +66.2% | +42.2% | |
| – | – | – | +68.8% | +51.1% | |
| – | – | – | – | – | |
| – | +0.0% | -62.6% | +4.7% | -14.4% | |
| – | +10,615.7% | +221.0% | +122.9% | -24.7% | |
| – | – | – | – | – | |
| – | +0.0% | +231.0% | +0.3% | +2.9% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.